| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Molecular Thyroid Research Unit Medizinische Klinik (C.S., W.J., A.E.F.), and Department of Legal Medicine (W.E.), Klinikum Innenstadt, Ludwig-Maximilians-Universität, 80336 München, Germany
Address all correspondence and requests for reprints to: A. E. Heufelder, M.D., Medizinische Klinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität, Ziemssenstr. 1, 80336 München, Germany. E-mail: u7g11av{at}mail.lrz-muenchen.de
The ability to concentrate iodide is a fundamental property of normally functioning thyroid tissue and represents the first step in the production of thyroid hormones. Iodide uptake has been demonstrated in various extrathyroidal tissues, including salivary gland, gastric mucosa, and lactating mammary gland. Recently, cloning and molecular characterization of the human sodium iodide symporter (hNIS) have been reported; however, the patterns of hNIS gene expression in human tissues have remained unidentified. To examine the profiles of human hNIS gene expression in various normal human tissues, we performed high-stringency Northern blot analysis using a 32P-labeled hNIS-specific complementary DNA (cDNA) probe (nucleotides 11841667). To detect rare hNIS transcripts in small tissue samples, RT-PCR was performed with a pair of hNIS-specific oligonucleotide primers designed to amplify a portion (nucleotides 11841667) of the hNIS gene. hNIS-specific transcripts were confirmed by Southern hybridization using a digoxigenin-labeled internal hNIS-specific oligonucleotide probe (nucleotides 14601477). To monitor cDNA integrity and quantity, and to rule out DNA contamination and illegitimate transcription, all samples were coamplified with two pairs of intron-spanning primers designed to amplify fragments of the human ß-actin and thyroglobulin genes, respectively. Using Northern blot analysis, hNIS transcripts of approximately 4 kb were detected in thyroid gland and parotid gland but not in a broad range of endocrine and nonendocrine tissues. RT-PCR and Southern hybridization revealed hNIS gene expression in thyroid gland, salivary gland, parotid gland, submandibular gland, pituitary gland, pancreas, testis, mammary gland, gastric mucosa, prostate and ovary, adrenal gland, heart, thymus, and lung. By contrast, hNIS transcripts were not detected in normal orbital fibroblasts, colon, and nasopharyngeal mucosa. To further analyze hNIS gene sequences in parotid gland, mammary gland, and gastric mucosa, the EXPAND High Fidelity PCR System and three sets of overlapping NIS oligonucleotide primers were used for amplification and cloning. The resulting PCR products were subcloned into pBluescript-SK II (-) vector, and at least two independent cDNA clones derived from each tissue were subjected to automated sequencing. The nucleotide sequences of hNIS cDNA derived from parotid gland, mammary gland, and gastric mucosa revealed full identity with the recently published human thyroid-derived NIS cDNA sequence. In conclusion, our results demonstrate markedly variable levels of hNIS gene expression in several extrathyroidal tissues. Although the physiological role of hNIS in these tissues awaits further study, our results suggest that the capacity to actively transport iodine may be a feature common to several secretory and endocrine tissues. The diminished capacity to transport and concentrate iodide in extrathyroidal tissues (such as parotid gland, mammary gland, and gastric mucosa), compared with thyroid gland, does not seem to be caused by an altered primary structure of the hNIS cDNA. Variability of NIS gene expression levels in normal extrathyroidal tissues may rather be caused by differences in NIS gene transcriptional activity. Further studies will address this hypothesis and examine the mechanisms of tissue-specific regulation of NIS gene expression.
This article has been cited by other articles:
![]() |
T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dohan, A. De la Vieja, and N. Carrasco Hydrocortisone and Purinergic Signaling Stimulate Sodium/Iodide Symporter (NIS)-Mediated Iodide Transport in Breast Cancer Cells Mol. Endocrinol., May 1, 2006; 20(5): 1121 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Unterholzner, M. J. Willhauck, N. Cengic, M. Schutz, B. Goke, J. C. Morris, and C. Spitzweg Dexamethasone Stimulation of Retinoic Acid-Induced Sodium Iodide Symporter Expression and Cytotoxicity of 131-I in Breast Cancer Cells J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Capuco, C. P. Rice, R. L. Baldwin VI, D. D. Bannerman, M. J. Paape, W. R. Hare, A. C. W. Kauf, G. W. McCarty, C. J. Hapeman, A. M. Sadeghi, et al. Fate of dietary perchlorate in lactating dairy cows: Relevance to animal health and levels in the milk supply PNAS, November 8, 2005; 102(45): 16152 - 16157. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, D. Scarpelli, R. Bruno, L. Lacroix, E. Tosi, A. Gulino, et al. Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2321 - 2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Dwyer, E. R. Bergert, M. K. O'Connor, S. J. Gendler, and J. C. Morris In vivo Radioiodide Imaging and Treatment of Breast Cancer Xenografts after MUC1-Driven Expression of the Sodium Iodide Symporter Clin. Cancer Res., February 15, 2005; 11(4): 1483 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Merrill, R. A. Clewell, P. J. Robinson, A. M. Jarabek, J. M. Gearhart, T. R. Sterner, and J. W. Fisher PBPK Model for Radioactive Iodide and Perchlorate Kinetics and Perchlorate-Induced Inhibition of Iodide Uptake in Humans Toxicol. Sci., January 1, 2005; 83(1): 25 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Fragoso, V. Fernandez, R. Forteza, S. H Randell, M. Salathe, and G. E Conner Transcellular thiocyanate transport by human airway epithelia J. Physiol., November 15, 2004; 561(1): 183 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rivas, B. Mellstrom, J. R. Naranjo, and P. Santisteban Transcriptional Repressor DREAM Interacts with Thyroid Transcription Factor-1 and Regulates Thyroglobulin Gene Expression J. Biol. Chem., August 6, 2004; 279(32): 33114 - 33122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, Y. Kanamoto, L. H. Che, K. Taki, F. Moatamed, J. J. Schultz, and G. A. Brent Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models Cancer Res., January 1, 2004; 64(1): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Nair, S Basu, and H Pakhale Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma Br. J. Radiol., January 1, 2004; 77(913): 63 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rillema and M. A. Hill Pendrin Transporter Carries Out Iodide Uptake into MCF-7 Human Mammary Cancer Cells Experimental Biology and Medicine, October 1, 2003; 228(9): 1078 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spitzweg, I. V. Scholz, E. R. Bergert, D. J. Tindall, C. Y. F. Young, B. Goke, and J. C. Morris Retinoic Acid-Induced Stimulation of Sodium Iodide Symporter Expression and Cytotoxicity of Radioiodine in Prostate Cancer Cells Endocrinology, August 1, 2003; 144(8): 3423 - 3432. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clewell, E. A. Merrill, K. O. Yu, D. A. Mahle, T. R. Sterner, J. W. Fisher, and J. M. Gearhart Predicting Neonatal Perchlorate Dose and Inhibition of Iodide Uptake in the Rat during Lactation Using Physiologically-Based Pharmacokinetic Modeling Toxicol. Sci., August 1, 2003; 74(2): 416 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Merrill, R. A. Clewell, J. M. Gearhart, P. J. Robinson, T. R. Sterner, K. O. Yu, D. R. Mattie, and J. W. Fisher PBPK Predictions of Perchlorate Distribution and Its Effect on Thyroid Uptake of Radioiodide in the Male Rat Toxicol. Sci., June 1, 2003; 73(2): 256 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clewell, E. A. Merrill, K. O. Yu, D. A. Mahle, T. R. Sterner, D. R. Mattie, P. J. Robinson, J. W. Fisher, and J. M. Gearhart Predicting Fetal Perchlorate Dose and Inhibition of Iodide Kinetics during Gestation: A Physiologically-Based Pharmacokinetic Analysis of Perchlorate and Iodide Kinetics in the Rat Toxicol. Sci., June 1, 2003; 73(2): 235 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Wapnir, M. van de Rijn, K. Nowels, P. S. Amenta, K. Walton, K. Montgomery, R. S. Greco, O. Dohan, and N. Carrasco Immunohistochemical Profile of the Sodium/Iodide Symporter in Thyroid, Breast, and Other Carcinomas Using High Density Tissue Microarrays and Conventional Sections J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1880 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Schipper, A. Weber, M. Behe, R. Goke, W. Joba, H. Schmidt, T. Bert, B. Simon, R. Arnold, A. E. Heufelder, et al. Radioiodide Treatment after Sodium Iodide Symporter Gene Transfer Is a Highly Effective Therapy in Neuroendocrine Tumor Cells Cancer Res., March 15, 2003; 63(6): 1333 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Selmi-Ruby, C. Watrin, S. Trouttet-Masson, F. Bernier-Valentin, V. Flachon, Y. Munari-Silem, and B. Rousset The Porcine Sodium/Iodide Symporter Gene Exhibits an Uncommon Expression Pattern Related to the Use of Alternative Splice Sites not Present in the Human or Murine Species Endocrinology, March 1, 2003; 144(3): 1074 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance Endocr. Rev., February 1, 2003; 24(1): 48 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rillema and M. A. Hill Prolactin regulation of the pendrin-iodide transporter in the mammary gland Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E25 - E28. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Kloos, V. Duvuuri, S. M. Jhiang, K. V. Cahill, J. A. Foster, and J. A. Burns Nasolacrimal Drainage System Obstruction from Radioactive Iodine Therapy for Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5817 - 5820. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chung Sodium Iodide Symporter: Its Role in Nuclear Medicine J. Nucl. Med., September 1, 2002; 43(9): 1188 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rillema, C. H. Williams, J. Moulden, and K. L. Golden Effect of Insulin on Iodide Uptake in Mouse Mammary Gland Explants Experimental Biology and Medicine, January 1, 2002; 227(1): 32 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Castro, E. R. Bergert, J. R. Goellner, I. D. Hay, and J. C. Morris Immunohistochemical Analysis of Sodium Iodide Symporter Expression in Metastatic Differentiated Thyroid Cancer: Correlation with Radioiodine Uptake J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5627 - 5632. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spitzweg, K. J. Harrington, L. A. Pinke, R. G. Vile, and J. C. Morris The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3327 - 3335. [Full Text] [PDF] |
||||
![]() |
H. Shimura, H. Suzuki, A. Miyazaki, F. Furuya, K. Ohta, K. Haraguchi, T. Endo, and T. Onaya Transcriptional Activation of the Thyroglobulin Promoter Directing Suicide Gene Expression by Thyroid Transcription Factor-1 in Thyroid Cancer Cells Cancer Res., May 1, 2001; 61(9): 3640 - 3646. [Abstract] [Full Text] |
||||
![]() |
R. P. M. Biscolla, J. M. Cerutti, and R. M. B. Maciel Detection of Recurrent Thyroid Cancer by Sensitive Nested Reverse Transcription-Polymerase Chain Reaction of Thyroglobulin and Sodium/Iodide Symporter Messenger Ribonucleic Acid Transcripts in Peripheral Blood J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3623 - 3627. [Abstract] [Full Text] |
||||
![]() |
J. A. Rillema, T. X. Yu, and S. M. Jhiang Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E769 - E772. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Ramos, C. V. Teixeira, M. C. F. Passos, C. C. Pazos-Moura, P. C. Lisboa, F. H. Curty, and E. G. de Moura Low-Protein Diet Changes Thyroid Function in Lactating Rats Experimental Biology and Medicine, September 1, 2000; 224(4): 256 - 263. [Abstract] [Full Text] |
||||
![]() |
D. B. Shennan and M. Peaker Transport of Milk Constituents by the Mammary Gland Physiol Rev, July 1, 2000; 80(3): 925 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boland, M. Ricard, P. Opolon, J.-M. Bidart, P. Yeh, S. Filetti, M. Schlumberger, and M. Perricaudet Adenovirus-mediated Transfer of the Thyroid Sodium/Iodide Symporter Gene into Tumors for a Targeted Radiotherapy Cancer Res., July 1, 2000; 60(13): 3484 - 3492. [Abstract] [Full Text] |
||||
![]() |
J. A. Rillema, S. Collins, and C. H. Williams Prolactin Stimulation of Iodide Uptake and Incorporation into Protein Is Polyamine-Dependent in Mouse Mammary Gland Explants Experimental Biology and Medicine, May 1, 2000; 224(1): 41 - 44. [Abstract] [Full Text] |
||||
![]() |
M. T. Kilbane, R. A. Ajjan, A. P. Weetman, R. Dwyer, E. W. M. McDermott, N. J. OHiggins, and P. P. A. Smyth Tissue Iodine Content and Serum-Mediated 125I Uptake-Blocking Activity in Breast Cancer J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1245 - 1250. [Abstract] [Full Text] |
||||
![]() |
C. Spitzweg, W. Joba, K. Schriever, J. R. Goellner, J. C. Morris, and A. E. Heufelder Analysis of Human Sodium Iodide Symporter Immunoreactivity in Human Exocrine Glands J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4178 - 4184. [Abstract] [Full Text] |
||||
![]() |
C. Spitzweg, S. Zhang, E. R. Bergert, M. R. Castro, B. McIver, A. E. Heufelder, D. J. Tindall, C. Y. F. Young, and J. C. Morris Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines Cancer Res., May 1, 1999; 59(9): 2136 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cann, J. P. van Netten, and D. W. Glover Iodide Accumulation in Extrathyroidal Tissues J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 821 - 821. [Full Text] |
||||
![]() |
R. B. Mandell, L. Z. Mandell, and C. J. Link Jr. Radioisotope Concentrator Gene Therapy Using the Sodium/Iodide Symporter Gene Cancer Res., February 1, 1999; 59(3): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, J. J. Schultz, L. S. Johnson, M. Huang, and G. A. Brent Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line PNAS, July 18, 2000; 97(15): 8519 - 8524. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |